These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1620204)

  • 21. Analysis and use of qualitative data.
    Sidani S; Sechrest L
    NIDA Res Monogr; 1996; 166():292-309. PubMed ID: 8818179
    [No Abstract]   [Full Text] [Related]  

  • 22. Should pregnant women be screened for drugs of abuse?
    Byrne B; Cotter A; Molloy E; Turner M
    Ir Med J; 1998; 91(1):29. PubMed ID: 9563256
    [No Abstract]   [Full Text] [Related]  

  • 23. Motivational interviewing.
    Gibson A; Gibson T
    Pract Midwife; 2000 Jan; 3(1):32-5. PubMed ID: 11029954
    [No Abstract]   [Full Text] [Related]  

  • 24. Issues in classification in meta-analysis in substance abuse prevention research.
    Hansen WB; Rose LA
    NIDA Res Monogr; 1997; 170():183-201. PubMed ID: 9154258
    [No Abstract]   [Full Text] [Related]  

  • 25. Cocaine use during pregnancy: implications for physicians.
    Aronson RA; Hunt LH
    Wis Med J; 1990 Mar; 89(3):105-10. PubMed ID: 2321404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use and misuse of repeated measures designs.
    Barcikowski RS; Robey RR
    NIDA Res Monogr; 1994; 142():302-41. PubMed ID: 9243540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preventive ethics strategies for drug abuse during pregnancy.
    Chervenak FA; McCullough LB
    J Clin Ethics; 1990; 1(2):157-8. PubMed ID: 2131075
    [No Abstract]   [Full Text] [Related]  

  • 28. [Birth and maternal addictive behaviors].
    Thibault P
    Soins Pediatr Pueric; 2006; (231):15. PubMed ID: 17017640
    [No Abstract]   [Full Text] [Related]  

  • 29. Implications for New York State policy.
    Lundine S
    Bull N Y Acad Med; 1991; 67(3):315-9. PubMed ID: 1868285
    [No Abstract]   [Full Text] [Related]  

  • 30. Hypothesis testing and the EU-Dap evaluation of the Unplugged curriculum.
    Gorman DM
    Prev Med; 2009 Jun; 48(6):604-5; author reply 606-7. PubMed ID: 19168091
    [No Abstract]   [Full Text] [Related]  

  • 31. New statistical methods for substance use prevention research.
    Collins LM; Seitz LA
    NIDA Res Monogr; 1994; 142():1-12. PubMed ID: 9243531
    [No Abstract]   [Full Text] [Related]  

  • 32. Conducting a treatment research project in a medical center-based program for chemically dependent pregnant women.
    Mason E
    NIDA Res Monogr; 1996; 166():22-31. PubMed ID: 8818163
    [No Abstract]   [Full Text] [Related]  

  • 33. [The pregnant drug addict: great need for a concerted effort for a growing clientele of "narcobabies"].
    Ege P
    Sygeplejersken; 1981 Jan; 81(2):16-21. PubMed ID: 6908258
    [No Abstract]   [Full Text] [Related]  

  • 34. Policies towards pregnancy and addiction. Sticks without carrots.
    Chavkin W; Wise PH; Elman D
    Ann N Y Acad Sci; 1998 Jun; 846():335-40. PubMed ID: 9668420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention intervention research: focus and perspective.
    Cázares A
    NIDA Res Monogr; 1994; 139():5-35. PubMed ID: 8742549
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of substance abuse during pregnancy and infant outcome.
    Little BB; Snell LM; Van Beveren TT; Crowell RB; Trayler S; Johnston WL
    Am J Perinatol; 2003 Jul; 20(5):255-62. PubMed ID: 13680509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Promoting healthy habits in pregnancy.
    Rayburn WF; Phelan ST
    Obstet Gynecol Clin North Am; 2008 Sep; 35(3):385-400, viii. PubMed ID: 18760226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correction for the design effect in school-based substance use and abuse prevention research: sample size requirements and analysis considerations.
    Dielman TE
    NIDA Res Monogr; 1994; 139():115-25. PubMed ID: 8742554
    [No Abstract]   [Full Text] [Related]  

  • 39. Issues and challenges in coding interventions for meta-analysis of prevention research.
    Devine EC
    NIDA Res Monogr; 1997; 170():130-46. PubMed ID: 9154255
    [No Abstract]   [Full Text] [Related]  

  • 40. [Patterns and modalities of illicit drug consumption in France].
    Apaire E
    Bull Acad Natl Med; 2008 Feb; 192(2):261-70; discussion 270-4. PubMed ID: 18819681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.